The Immunological Frontier: How Targeted Therapy and Immunotherapy are Disrupting the Future of Glioma Treatment
The future growth of the Glioma Diagnosis and Treatment Market, particularly the aggressive Glioblastoma Multiforme (GBM) segment, is heavily reliant on the successful commercialization of **Targeted Therapy and Immunotherapy**. These advanced modalities represent the most significant potential breakthroughs against a disease that has long resisted conventional surgery, chemotherapy, and...
0 Comments 0 Shares 507 Views 0 Reviews